What do you think?
Rate this book
Our Future is Biotech: A Plain English Guide to How a Tech Revolution is Changing Our Lives and Our Health for the Better
"An essential read for anyone committed to understanding the technologies that will define our future." CHRISTIAN ANGERMAYER, BIOTECH ENTREPRENEUR AND FOUNDER OF APEIRON INVESTMENT GROUP
Welcome to the biotech revolution
In the last century, technology has transformed the human experience across the world. This has been super-charged by the arrival of the internet, smart phones, AI and machine learning, and created trillion-plus dollar companies and household names like Apple, Amazon, Google and Microsoft.
Our Future is Biotech explains why biotech is because our biggest remaining challenges as a species concern biological systems.
Biotech companies will solve our most intractable problems, from cancer, dementia, obesity and diabetes to elderly care, mental health conditions, and even clean power generation, agricultural production and environmental degradation.
Biotech means that we can all live better, safer, healthier, wealthier, happier, and longer lives.
The industry has already delivered "miracle cures" for several diseases, and there is more to come. But despite this, few people are aware of the phenomenal progress being made. Our Future is Biotech addresses this, explaining what biotech is, what is coming next, and how you might profit from it too.
Tech has been the most important theme for human progress for the last century. Biotech is next.
Welcome to the biotech revolution
In the last century, technology has transformed the human experience across the world. This has been super-charged by the arrival of the internet, smart phones, AI and machine learning, and created trillion-plus dollar companies and household names like Apple, Amazon, Google and Microsoft.
Our Future is Biotech explains why biotech is because our biggest remaining challenges as a species concern biological systems.
Biotech companies will solve our most intractable problems, from cancer, dementia, obesity and diabetes to elderly care, mental health conditions, and even clean power generation, agricultural production and environmental degradation.
Biotech means that we can all live better, safer, healthier, wealthier, happier, and longer lives.
The industry has already delivered "miracle cures" for several diseases, and there is more to come. But despite this, few people are aware of the phenomenal progress being made. Our Future is Biotech addresses this, explaining what biotech is, what is coming next, and how you might profit from it too.
Tech has been the most important theme for human progress for the last century. Biotech is next.
372 pages, Kindle Edition
Published August 29, 2024
36 people are currently reading
179 people want to read
About the author
Andrew Craig
38 books40 followersAndrew Craig graduated in Economics and International Politics in 1997. His first job took him to Washington DC where he worked for a US Congressman on Capitol Hill. Since then, he has spent over fifteen years working in financial markets for various firms in London and New York. These have included UBS, Credit Agricole (France’s biggest bank) and SEB (one of Sweden’s largest banks). He is currently a partner at boutique investment bank, WG Partners.
During his career, Andrew has met and travelled with the top management teams of several hundred companies and been involved with the stock market flotation (IPO) of the likes of Burberry, Campari, easyJet, HMV, lastminute.com, Carluccio’s and the Carbon Trust. Andrew does not claim to be a financial “guru”, but he is confident he can help you. At the most basic level his view is simply that you really owe it to yourself to learn enough about money and investment to get your financial house in order. The rewards for doing this are life-changing.
Learning about money is also nowhere near as difficult as you may previously have thought. You can learn how to do a perfectly good job with your money just as easily as you learnt how to drive, for example. Andrew would argue that it is crazy that nearly everyone accepts that it is normal and entirely possible to learn how to drive but most people think that learning about money is too hard or just not for them. Real financial literacy should be taught at every school in the country. To that end, he knows that you will find the information in How to Own the World truly life changing...
During his career, Andrew has met and travelled with the top management teams of several hundred companies and been involved with the stock market flotation (IPO) of the likes of Burberry, Campari, easyJet, HMV, lastminute.com, Carluccio’s and the Carbon Trust. Andrew does not claim to be a financial “guru”, but he is confident he can help you. At the most basic level his view is simply that you really owe it to yourself to learn enough about money and investment to get your financial house in order. The rewards for doing this are life-changing.
Learning about money is also nowhere near as difficult as you may previously have thought. You can learn how to do a perfectly good job with your money just as easily as you learnt how to drive, for example. Andrew would argue that it is crazy that nearly everyone accepts that it is normal and entirely possible to learn how to drive but most people think that learning about money is too hard or just not for them. Real financial literacy should be taught at every school in the country. To that end, he knows that you will find the information in How to Own the World truly life changing...
Ratings & Reviews
Friends & Following
Create a free account to discover what your friends think of this book!
Community Reviews
Displaying 1 - 18 of 18 reviews
December 29, 2024
I am a scientist that works on the intersection between the microbiome and behavior. The premise of this book intrigued me for its boldness. The claims that Craig makes throughout the book are definitely founded in current research, yet perhaps a bit too optimistic in their nature. While I fully support his call to action to fund more biotech research, I do think that his proposed timeline for how quickly these developments will occur should be considered with some caution. The overall book is well-written, compelling and definitely an interesting read for those that are still new to both science and finance. I appreciate the author’s attempts to calm the public and advocate for more faith in scientific institutions. However, I will caution the reader to be critical of the treatment of “diseases of modernity” as this type of terminology is a slippery slope towards eugenics. I am grateful for the author and publisher’s permission to read this early and I look forward to seeing it hit the shelves.
May 25, 2025
all reviews in one place:
night mode reading
; skaitom nakties rezimu
My Opinion: Or maybe not. Here’s a thing: a lot of things author speaks about, whilst cheering Europe and the rest of the world to go ahead and strive to do it all too (even fully acknowledging the disparity in funding), are still being done in USA. And a lot of said things are being dismantled as we speak, as I literally write this. Our future is being compromised, and the only hope is to either stop those who are gambling us away, or to make sure others can pick up the slack. The book is very good, and very hopeful, as I said. But it just feels like a stab in the back too. Do read it, if only so you know what we must fight for. No, nothing is doomed. Nothing is ever doomed whilst we draw breath.
A solid read, 5 out of 5. Here’s to hoping imbeciles don’t kill us all. Here’s to hoping we have spine enough to stand up to bullies. And here’s to hoping we manage it.
My Opinion: Or maybe not. Here’s a thing: a lot of things author speaks about, whilst cheering Europe and the rest of the world to go ahead and strive to do it all too (even fully acknowledging the disparity in funding), are still being done in USA. And a lot of said things are being dismantled as we speak, as I literally write this. Our future is being compromised, and the only hope is to either stop those who are gambling us away, or to make sure others can pick up the slack. The book is very good, and very hopeful, as I said. But it just feels like a stab in the back too. Do read it, if only so you know what we must fight for. No, nothing is doomed. Nothing is ever doomed whilst we draw breath.
A solid read, 5 out of 5. Here’s to hoping imbeciles don’t kill us all. Here’s to hoping we have spine enough to stand up to bullies. And here’s to hoping we manage it.
October 31, 2024
I am a scientist working in cancer. I must say, I am very pleasantly surprised by the overall grasp and up-to-date information Andrew Craig has compiled and managed to deliver in a very lay-friendly way. Respect for all the sources he has read and understood!
I myself didn’t know about some of the most recent developments from other fields and it was very exciting to see a glimpse of hope in the otherwise very bleak looking future. I wish I had his optimism…:
I myself didn’t know about some of the most recent developments from other fields and it was very exciting to see a glimpse of hope in the otherwise very bleak looking future. I wish I had his optimism…:
August 31, 2024
The premise of this book is that the next revolution in technology will be Biotech as the biggest remaining challenges for humanity concern biological systems.
The book is divided into 3 sections:
The first section is on the investment opportunity that Biotech represents and why there are issues raising investment for companies based outwith the US.
The second section is on personalised medicine and the concept of Medicine 3.0 which is the idea of maintaining lifelong overall health and preventing disease from happening in the first place (as opposed to Medicine 2.0 which treats disease and increases lifespan).
The third section lists the technological advances in biotechnology that have happened already and are on the cusp of happening.
The section on investment will be of interest to all life sciences start-up founders raising investment.
Increasingly, UK Biotech companies are looking to set up operations in the US and ultimately raise investment there and the lack of investment opportunities in the UK also translates into a lack of available lab space and facilities here too.
It then results in our best biotech startups either relocating to the US or being acquired by US competitors.
This book says that that can’t last and that eventually the technological progress and relative attractiveness of UK companies at more appealing prices will swing the balance.
I hope that is correct!
The middle section contains details of how factors such as diet, exercise, sleep, breathing can improve health and makes important points about the lack of training in nutrition that doctors get and about a move towards personalised medicine specific to the individual.
Specifically the author writes about how by understanding dysbiosis (imbalance within the microbiome of bacteria etc in the body), he was able to cure himself from a debilitating illness, ulcerative colitis.
The final section lists many of the technological advances that have happened and are happening. The large amounts of money involved in biotech to cover trials and regulatory approvals and then production and sales are one factor that I think holds back the sector but another is that people think that it is too complicated to understand so they stick to what they know.
This book is one of the best that I have read for addressing that as it describes subjects such as small and large molecules, antimicrobial resistance, stem cells, CRISPR, PCR and NGS in a way that a non-scientist can follow easily.
I read about many Nobel Prize winners whom I was not previously aware of and was struck by how many of the developments had happened relatively recently, since the turn of the century and the future potential from eg: 3D printing organs and nanotechnology.
The book also describes the convergence of technologies with biotech at the core and being used to also address climate related issues such as biofuel and bioremediation (removing contaminants from the environment). Also a world where animals would no longer be required for food nor for animal testing and the environmental impact of that. And the biotech work can be turbocharged by the addition of the data processing power that we now have and by artificial intelligence.
The overall message of the book is a very positive one and the author states that one of his aims is to counteract the negative news that gets reported in the mainstream press.
This book definitely had that effect for me and made me have a more positive outlook about the future!
(It is also worth noting that the book is a great starting point for further reading on this subject with references to many other books on each point covered.
I have added Outlive: The Science & Art of Longevityand The Code Breaker: Jennifer Doudna, Gene Editing, and the Future of the Human Race to my reading list as a result)
The book is divided into 3 sections:
The first section is on the investment opportunity that Biotech represents and why there are issues raising investment for companies based outwith the US.
The second section is on personalised medicine and the concept of Medicine 3.0 which is the idea of maintaining lifelong overall health and preventing disease from happening in the first place (as opposed to Medicine 2.0 which treats disease and increases lifespan).
The third section lists the technological advances in biotechnology that have happened already and are on the cusp of happening.
The section on investment will be of interest to all life sciences start-up founders raising investment.
Increasingly, UK Biotech companies are looking to set up operations in the US and ultimately raise investment there and the lack of investment opportunities in the UK also translates into a lack of available lab space and facilities here too.
It then results in our best biotech startups either relocating to the US or being acquired by US competitors.
This book says that that can’t last and that eventually the technological progress and relative attractiveness of UK companies at more appealing prices will swing the balance.
I hope that is correct!
The middle section contains details of how factors such as diet, exercise, sleep, breathing can improve health and makes important points about the lack of training in nutrition that doctors get and about a move towards personalised medicine specific to the individual.
Specifically the author writes about how by understanding dysbiosis (imbalance within the microbiome of bacteria etc in the body), he was able to cure himself from a debilitating illness, ulcerative colitis.
The final section lists many of the technological advances that have happened and are happening. The large amounts of money involved in biotech to cover trials and regulatory approvals and then production and sales are one factor that I think holds back the sector but another is that people think that it is too complicated to understand so they stick to what they know.
This book is one of the best that I have read for addressing that as it describes subjects such as small and large molecules, antimicrobial resistance, stem cells, CRISPR, PCR and NGS in a way that a non-scientist can follow easily.
I read about many Nobel Prize winners whom I was not previously aware of and was struck by how many of the developments had happened relatively recently, since the turn of the century and the future potential from eg: 3D printing organs and nanotechnology.
The book also describes the convergence of technologies with biotech at the core and being used to also address climate related issues such as biofuel and bioremediation (removing contaminants from the environment). Also a world where animals would no longer be required for food nor for animal testing and the environmental impact of that. And the biotech work can be turbocharged by the addition of the data processing power that we now have and by artificial intelligence.
The overall message of the book is a very positive one and the author states that one of his aims is to counteract the negative news that gets reported in the mainstream press.
This book definitely had that effect for me and made me have a more positive outlook about the future!
(It is also worth noting that the book is a great starting point for further reading on this subject with references to many other books on each point covered.
I have added Outlive: The Science & Art of Longevityand The Code Breaker: Jennifer Doudna, Gene Editing, and the Future of the Human Race to my reading list as a result)
January 5, 2025
A "meh" book.
It's a superficial overview of biotech, which might be perfect for someone who knows little about the field.
If you know the basics, you'll be disappointed.
Twice he quotes Thomas Babbington Macaulay saying the same wise thing: "On what principle is it that with nothing but improvement behind us, we are to expect nothing but deterioration before us."
The book says, "Andrew Craig is a best-selling finance author, entrepreneur, and the founder of a personal finance website."
He's not exactly the person you might expect to write about biotech.
Although his strength is writing in plain English, his lack of depth of knowledge results in a superficial coverage of the field.
He alludes to this when he writes:
"This chapter has necessarily been something of a whistle-stop tour through what biotech is likely to be able to do 'without us.' Each one off the industries and applications covered over the last few pages would merit a book in their own right but I hope this brief canter through them has served to give the reader a flavour for just how exciting some of this technological progress will be."
He tries to describe the intersection of biotechnology, finance, and societal impact.
- Content Overview: The book overviews current and emerging biotechnologies, particularly in healthcare. It discusses the exponential growth of the biotech industry, integrating insights from various fields, including artificial intelligence and digital manufacturing. Craig aims to make complex concepts accessible to readers without a STEM background.
- While the book is engaging and informative, it may be more appealing to those with a basic understanding of biotechnology. It is reminiscent of an introductory course in biotech, providing a broad perspective rather than deep technical insights.
- Optimism vs. Realism: Craig's optimistic view on the rapid advancements in biotechnology is commendable, although it may lead to unrealistic expectations regarding the pace of technological developments.
- Challenges Discussed: The book addresses significant challenges facing the biotech sector, including public perception, regulatory hurdles, and the complexities of medical implementation. Craig emphasizes shifting from traditional "sick care" to a more proactive "health care" approach.
- The book occasionally reads like a promotional piece rather than an objective analysis.
- Writing Style: Craig's writing is clear and engaging, making complex scientific topics understandable. I appreciate his effort to demystify biotechnology for a general audience.
Overall, "Our Future is Biotech" is a resource for those interested in biotechnology's potential impact on society and health, but I didn't learn that much from it. If you know little about the field, you'll give it 5 stars because it's excellent at the broad overview.
It's a superficial overview of biotech, which might be perfect for someone who knows little about the field.
If you know the basics, you'll be disappointed.
Twice he quotes Thomas Babbington Macaulay saying the same wise thing: "On what principle is it that with nothing but improvement behind us, we are to expect nothing but deterioration before us."
The book says, "Andrew Craig is a best-selling finance author, entrepreneur, and the founder of a personal finance website."
He's not exactly the person you might expect to write about biotech.
Although his strength is writing in plain English, his lack of depth of knowledge results in a superficial coverage of the field.
He alludes to this when he writes:
"This chapter has necessarily been something of a whistle-stop tour through what biotech is likely to be able to do 'without us.' Each one off the industries and applications covered over the last few pages would merit a book in their own right but I hope this brief canter through them has served to give the reader a flavour for just how exciting some of this technological progress will be."
He tries to describe the intersection of biotechnology, finance, and societal impact.
- Content Overview: The book overviews current and emerging biotechnologies, particularly in healthcare. It discusses the exponential growth of the biotech industry, integrating insights from various fields, including artificial intelligence and digital manufacturing. Craig aims to make complex concepts accessible to readers without a STEM background.
- While the book is engaging and informative, it may be more appealing to those with a basic understanding of biotechnology. It is reminiscent of an introductory course in biotech, providing a broad perspective rather than deep technical insights.
- Optimism vs. Realism: Craig's optimistic view on the rapid advancements in biotechnology is commendable, although it may lead to unrealistic expectations regarding the pace of technological developments.
- Challenges Discussed: The book addresses significant challenges facing the biotech sector, including public perception, regulatory hurdles, and the complexities of medical implementation. Craig emphasizes shifting from traditional "sick care" to a more proactive "health care" approach.
- The book occasionally reads like a promotional piece rather than an objective analysis.
- Writing Style: Craig's writing is clear and engaging, making complex scientific topics understandable. I appreciate his effort to demystify biotechnology for a general audience.
Overall, "Our Future is Biotech" is a resource for those interested in biotechnology's potential impact on society and health, but I didn't learn that much from it. If you know little about the field, you'll give it 5 stars because it's excellent at the broad overview.
November 5, 2024
I have been following Andrew for a while and quickly became a fan of his work and endeavors in teaching personal finance. This, in my opinion, is something that our (global) educational system lacks the most (and I believe Andrew agrees with me on this regard).
For the past year, his previous books are what first got me into learning about economics, personal finance & investing for retirement (due to the many limitations that any government will present in the future).
His argument through his books: the stock market is a wealth machine, but above that, it is tool on "human progress" (think about cars, TVs, the internet, etc). He presents "compounding" as the driving force behind this development, the power of "the exponentials". I love his optimism and do agree that the news/media play a crucial role on our (negative!) view on the world around us, specially when we end up not acknowledging the many developments (& progress) made in the last decades (and centuries).
In this book, his language, simple, yet straightforward, shows his belief on biotech as the next big revolution for the decades to come that will replace many technology-based companies currently topping the stock market (and we should be follow this progress closely).
Tackling human health problems such as cancer, IBS and many other diseases (including aging) may be the next big challenges to solve (and according to him, we may be very close do so). Why haven't we already? From an financial standpoint, most companies solving these problems (particularly in Europe, UK, Australia) require additional capital that is not easily available because of the lack of domestic investment drive by the people living there (I would argue myself that high taxation in some of these countries also play a crucial role in underinvestment) - which leads to most companies moving their establishments to the US.
On a different note: I wish he had mentioned a bit more about the role of biotech for solving global warming, energy generation & also biological computing. Nevertheless, I can understand if not a lot of information is easily available in such areas.
4.5*
For the past year, his previous books are what first got me into learning about economics, personal finance & investing for retirement (due to the many limitations that any government will present in the future).
His argument through his books: the stock market is a wealth machine, but above that, it is tool on "human progress" (think about cars, TVs, the internet, etc). He presents "compounding" as the driving force behind this development, the power of "the exponentials". I love his optimism and do agree that the news/media play a crucial role on our (negative!) view on the world around us, specially when we end up not acknowledging the many developments (& progress) made in the last decades (and centuries).
In this book, his language, simple, yet straightforward, shows his belief on biotech as the next big revolution for the decades to come that will replace many technology-based companies currently topping the stock market (and we should be follow this progress closely).
Tackling human health problems such as cancer, IBS and many other diseases (including aging) may be the next big challenges to solve (and according to him, we may be very close do so). Why haven't we already? From an financial standpoint, most companies solving these problems (particularly in Europe, UK, Australia) require additional capital that is not easily available because of the lack of domestic investment drive by the people living there (I would argue myself that high taxation in some of these countries also play a crucial role in underinvestment) - which leads to most companies moving their establishments to the US.
On a different note: I wish he had mentioned a bit more about the role of biotech for solving global warming, energy generation & also biological computing. Nevertheless, I can understand if not a lot of information is easily available in such areas.
4.5*
October 10, 2025
Personally, I am a enthusiast about psychedelic-derived drugs to tackle psychiatric issues which modern therapy and pharmaceuticals are unable to solve. So, in the name of confirmation bias, I bought this book on biotech.
Perhaps a bit hype-hype, but I felt it gave me a deeper understanding of what biotech is and what the future hopefully will bring. It focuses mostly on humans, such as using designer-antibodies based on molecules found in sharks to tackle various diseases (crazy!), but also talks about biotech's role in other areas such as tackling the draining of nutrients in our soil. The author is clearly personally invested, so it felt engaging too.
I also liked the focus of the history of biotech to understand its future. The author argues, for instance, that not that long ago, diabetes type 1 was a death sentence. Today, we take the wonder drug insulin for granted. He uses such historic examples to illustrate today's issues; there are likely similar serious problems in 2025 which biotech suddenly can solve at a reasonable price in 20... something. Well reasoned enthusiasm is always nice!
It does have some flaws. It is a repetitive, the sentences are too long, and it uses just a bit too many pages time for a biotech book on health promoting behavior such as heat/cold exposure and exercise. Yet, learning about the challenges in areas such as big molecule medicine was stilig.
Perhaps a bit hype-hype, but I felt it gave me a deeper understanding of what biotech is and what the future hopefully will bring. It focuses mostly on humans, such as using designer-antibodies based on molecules found in sharks to tackle various diseases (crazy!), but also talks about biotech's role in other areas such as tackling the draining of nutrients in our soil. The author is clearly personally invested, so it felt engaging too.
I also liked the focus of the history of biotech to understand its future. The author argues, for instance, that not that long ago, diabetes type 1 was a death sentence. Today, we take the wonder drug insulin for granted. He uses such historic examples to illustrate today's issues; there are likely similar serious problems in 2025 which biotech suddenly can solve at a reasonable price in 20... something. Well reasoned enthusiasm is always nice!
It does have some flaws. It is a repetitive, the sentences are too long, and it uses just a bit too many pages time for a biotech book on health promoting behavior such as heat/cold exposure and exercise. Yet, learning about the challenges in areas such as big molecule medicine was stilig.
January 12, 2025
This is one of the most comprehensive books I have read on the past, present and future of bio technology.
The author has taken a much broader definition of the term.
The canvas covered includes medicine, health, lifespan, agriculture and power sectors. He spends a lot of time on how biotech can improve the health, fitness and lifespan of humans.
Stem cells, CRISPR, PCR (polymerase chain reaction), NGS (Next generation sequencing ) are covered in a reasonable bit of detail.
The discoveries of at least a dozen Nobel prize winners are elucidated for the common man reading the book.
The essence of the books written by many stalwarts of their respective fields of research - Mathew Walker, Wim Hof, Jenifer Doudna, Professor Sinclair, James Nestor, Peter Attia and David Robson - to name a few are covered beautifully at the appropriate sections of the book.
This is a very ambitious effort and the erudition of the author is nonchalantly visible.
You get a full satisfaction after reading this - yes I know now that bio tech is the future and may be I should start investing in these stocks.
Great book. Go for it.
The author has taken a much broader definition of the term.
The canvas covered includes medicine, health, lifespan, agriculture and power sectors. He spends a lot of time on how biotech can improve the health, fitness and lifespan of humans.
Stem cells, CRISPR, PCR (polymerase chain reaction), NGS (Next generation sequencing ) are covered in a reasonable bit of detail.
The discoveries of at least a dozen Nobel prize winners are elucidated for the common man reading the book.
The essence of the books written by many stalwarts of their respective fields of research - Mathew Walker, Wim Hof, Jenifer Doudna, Professor Sinclair, James Nestor, Peter Attia and David Robson - to name a few are covered beautifully at the appropriate sections of the book.
This is a very ambitious effort and the erudition of the author is nonchalantly visible.
You get a full satisfaction after reading this - yes I know now that bio tech is the future and may be I should start investing in these stocks.
Great book. Go for it.
September 26, 2024
Andrew Craig's "Future of Biotech" provides an overview of some of the current and emerging biotechnologies that are shaping industry, primarily in the healthcare field. I think Craig does a fine job of explaining concepts and technologies in a clear way, despite all of the jargon in the fields. I do have a biological science background however, so I might have had an easier time with it than some; but anyone with a genuine interest in ever-evolving field of biotechnology should give this a read! I think Craig is very insightful when he discusses how the biotechnology field is growing exponentially rather then linearly - something not many folks might realize! It is very interesting to engage with biotechnology from not just a pure science standpoint, but to also consider larger impacts on society and the economy. This book has made me excited to see what future developments are waiting around the corner!
NetGalley provided the book for review.
NetGalley provided the book for review.
August 21, 2024
The book had some strong points. Craig is a big supporter of biotech and addresses some of the concerns people have. He also does a good job of explaining the relevant financial markets and regulations. I did find Craig overly optimistic based on exponential advances, but at least he is honest about it. On the other hand, although Craig writes openly that he is a fan of biotech, I felt that the tone of the book was more of a sales spiel than a source of information. I also found that the middle section of the book, about Medicine 3.0 was out of place and I skipped a lot of it. The final section of the book, on the science behind biotech was good, covering a lot of areas, but very, very briefly, was good but again the chapter on longevity added nothing to the book. Thank you to Netgalley and Nicholas Brealey US for the advance reader copy.
January 7, 2025
I have had invested in my own health did due to mitochondrial disease. Unfortunately quite a lot of the information in this book I was already aware of. It has slightly deepened my knowledge on health. However, what it did do is confirm to me was I am on the right track to have invested interest in the future of this field and how tech and health will blend. It helped me understand the financial markets of "biotech" and why stuff is taking so long to develop. I want to look more into CRISPR as it would have stopped me from having my disease if I was born maybe 50 years later.
I think the bibliography in the back will be useful.
Also it made me feel more positive about the future going into the new year which is nice with the constant stream of doom and gloom.
"Pessimists sound smart, optimists make money" - to quote the book
I think the bibliography in the back will be useful.
Also it made me feel more positive about the future going into the new year which is nice with the constant stream of doom and gloom.
"Pessimists sound smart, optimists make money" - to quote the book
January 17, 2025
I read the book as a layman in biotech, hence my rating and comment is based on such a perspective.
The first part of the book is about investment and finance in the domain, which did not interest me much. The second part started to get my interest in personal health on topics like medicine, diseases and various factors that can impact our health. The last part is what I like most ... covering many researches & developments in science and technologies from past to current plus possibilities in the future.
Subjects in biotech which the author pointed out in the book, some I have come across from other readings, has enlightened me after learning from the description which I can still comprehend. These include recombinant DNA to messenger RNA, monoclonal antibodies, ICI (immune checkpoint inhibitor), gene and cell therapy (autologous & allogeneic cell), stem cells (ESCs vs iPSCs), CRISPR, smaller protein-base biologic therapies, PCR (polymerase chain reaction), NGS (next-generation sequencing) etc.
The first part of the book is about investment and finance in the domain, which did not interest me much. The second part started to get my interest in personal health on topics like medicine, diseases and various factors that can impact our health. The last part is what I like most ... covering many researches & developments in science and technologies from past to current plus possibilities in the future.
Subjects in biotech which the author pointed out in the book, some I have come across from other readings, has enlightened me after learning from the description which I can still comprehend. These include recombinant DNA to messenger RNA, monoclonal antibodies, ICI (immune checkpoint inhibitor), gene and cell therapy (autologous & allogeneic cell), stem cells (ESCs vs iPSCs), CRISPR, smaller protein-base biologic therapies, PCR (polymerase chain reaction), NGS (next-generation sequencing) etc.
March 9, 2024
The book is excellently written and has broadened my understanding of various technologies and concepts that were previously unknown to me. As someone who enjoys reading about science and biotechnology, I found it to be very informative. I highly recommend it to anyone who shares similar interests. The book is easy to comprehend and effectively communicates complex scientific topics. I am grateful for the opportunity to access this book and extend my appreciation to Net Galley, the publisher, and the author.
December 2, 2024
5 stars because I found it a perfect introduction to the types of readings I want to do many more of. What for me works in this book, for others might act against it. It somewhat mixes an exploration of a huge potential of biotech industry to revolutionise society as a whole, and actionable prescriptions for individuals that are derived from existing achievements. One can get both good inspiration for healthier daily conduct and meaningful investment ideas.
December 29, 2024
Love past Andrew Craig books. This is a good in-depth look at a particular industry. Interesting.
February 28, 2025
This is mostly just a brief history of medicine and biotech. It doesn't say much about strategy or the future.
April 19, 2025
3.5 stars
Displaying 1 - 18 of 18 reviews